Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The Company has its manufacturing plant at Plot No. 37, 38, 39, 29, 30, 01 GIDC Sojitra, Dist. Anand – 387240, Gujarat, India since inception, spread across 6204.53 Sq. Mtrs. of land.
The Company got certified as ISO 9001-2008 in the year 2010. The Company penetrated the Pharmaceutical market with the CRAMS Model i.e. Contract Research And Manufacturing Services in which the Company emphasizes on:
- Process Optimization;
- Developing / Manufacturing the products specifically as per customer’s requirement and final application;
- Customized Packing / Labelling;
- Reliable Supply of final product;
- Highly focused to Iodine Chemistry.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
The Company currently provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs.
Infinium Pharmachem IPO – Details
| IPO Opening Date | 31 March 2023 |
| IPO Closing Date | 05 April 2023 |
| Issue Type | Fixed Price Issue IPO |
| Issue Size | 18,75,000 Shares Worth ₹25.31 Crore Fresh Issue: 18,75,000 Shares Worth ₹25.31 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹135 |
| Market Lot | 1000 Shares |
| Min Order | 1000 Shares (1 Lot) |
| Listing At | NSE SME |
| Register | Bigshare Services Pvt Ltd |
| Retail Shares Offered | 50% |
| NII (HNI) Shares Offered | 50% |
Infinium Pharmachem IPO – Date Schedule
| IPO Open Date | 31 March 2023 |
| IPO Close Date | 05 March 2023 |
| Basis of Allotment | 11 April 2023 |
| Initiation of Refunds | 12 April 2023 |
| Credit of Shares to Demat Account | 13 April 2023 |
| IPO Listing Date | 17 April 2023 |
Infinium Pharmachem IPO – Lots Size & Price
| Application | Lots | Shares | Amount ( Cut-Off) |
| Minimum | 1 | 1000 | 1,35,000 |
| Maximum | 1 | 1000 | 1,35,000 |
Competitive Strengths
- Expertise of the Company in Research and Development (R&D) (200+ Iodine Derivatives Researched & Developed);
- Strong growth in emerging market business;
- Expanding reach to over 15+ countries across the globe while significantly increasing customer base in India too.
- Focus on Strategy;
- Dependable suppliers: The Company has a good quantity of competent raw material suppliers, which allows it to bypass many supply chain bottlenecks.
Company Promoters
- Mr. Sanjaykumar Viththalbhai Patel
- Mr. Pravin Bhadabhai Madhani
- Mr. Mitesh Lavjibhai Chikhaliya
Object Of The Issue
- Marketing and Branding Expenses (including Registration in Reach – Europe, other marketing expenses);
- Repayment of some of Existing Loans;
- Expansion of Existing Unit;
- To Meet Incremental Working Capital Requirements;
- General Corporate Purpose;
- To meet Public Issue Expenses.
Company Financial
| Particulars | Total Revenue | Total Expense | Profit After Tax |
|---|---|---|---|
| 31 March 2020 | 39.41 | 38.17 | 0.93 |
| 31 March 2021 | 71.15 | 67.38 | 2.72 |
| 31 March 2022 | 100.05 | 91.42 | 6.10 |
| 30 September 2022 | 79.85 | 72.17 | 5.51 |
Infinium Pharmachem IPO Promoter Holding
| Pre Issue Share Holding | 41.75% |
| Post Issue Share Holding | 30.50% |
Infinium Pharmachem IPO Prospectus
Company Contact Information
| Infinium Pharmachem Limited 38 G.I.D.C Sojitra, Taluka – Sojitra, Dist. – Anand – 387240 Phone: +91-2692-238849 Email: info@infiniumpharmachem.com Website: https://infiniumpharmachem.com/ |
Infinium Pharmachem IPO Registrar
| Bigshare Services Pvt Ltd Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com Website: https://www.bigshareonline.com/ |
Infinium Pharmachem IPO Lead Manager(s)
| 1. Swastika Investmart Ltd |
Infinium Pharmachem IPO FAQs
| What is Infinium Pharmachem IPO? Infinium Pharmachem IPO is a SME IPO. The issue is priced at ₹135 per equity share. The IPO is to be listed on NSE SME. |
| When Infinium Pharmachem IPO will open? The IPO is to open on 31 March 2023 for NII and Retail Investors. |
| What is Infinium Pharmachem IPO Investors Portion? The investors portion for NII-50%, and Retail-50%. |
| How to Infinium Pharmachem IPO? You can apply Infinium Pharmachem IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Infinium Pharmachem IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Infinium Pharmachem”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Infinium Pharmachem IPO through Edelweiss? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Infinium Pharmachem”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Edelweiss. |
| What is Infinium Pharmachem IPO Size? Infinium Pharmachem IPO size is ₹25.25 crores. |
| What is Infinium Pharmachem IPO Price Band? Infinium Pharmachem IPO Price Band is ₹135. |
| What is Infinium Pharmachem IPO Minimum and Maximum Lot Size? The minimum bid is 1000 Shares with ₹1,35,000 amount while the maximum bid is 1000 shares with ₹1,35,000. |
| What is the Infinium Pharmachem IPO Allotment Date? Infinium Pharmachem IPO allotment date is 11 April 2023. |
| What is the Infinium Pharmachem IPO Listing Date? Infinium Pharmachem IPO listing date is 17 April 2023. The IPO is to list on NSE SME. |
